Chaitanya Hospital   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Kottayam India (1995)

Organization Overview

First Clinical Trial
2011
NCT01832454
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

CHAITANYA HOSPITAL | Chaitanya Hospital, Pune

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ataxia (Phase 2)

Atrophy (Phase 2)

Autistic Disorder (Phase 2)

Cerebellar Ataxia (Phase 2)

Cerebral Palsy (Phase 2)

Fibrosis (Phase 2)

Huntington Disease (Phase 2)

Intellectual Disability (Phase 2)

Kidney Failure, Chronic (Phase 2)

Liver Cirrhosis (Phase 2)

Multiple Sclerosis (Phase 2)

Muscular Dystrophies (Phase 2)

Muscular Dystrophy, Duchenne (Phase 2)

Optic Atrophy (Phase 2)

Optic Nerve Diseases (Phase 2)

Paralysis (Phase 2)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 2)

Retinitis (Phase 2)

Retinitis Pigmentosa (Phase 2)

Sclerosis (Phase 2)

Spinal Cord Injuries (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 16
  • # of Trial APIs: 6